As of 2024-12-12, the Fair Value of PMV Pharmaceuticals Inc (PMVP) is -4.97 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.57 USD, the upside of PMV Pharmaceuticals Inc is -416.72%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -25.35 | -34.44 | -57.85 | -73.32 | -68.96 | -51.98 |
| YoY growth | -44.53% | -35.86% | -67.97% | -26.74% | 5.95% | -33.83% |
| Market Cap (mil) | 81.25 |
| P/E | |
| Forward P/E |
| EPS | -0.99 |
| Avg earnings growth rate | -33.83% |
| TTM earnings | -51.47 |